Cognizant Technology Solutions Corporation (CTSH) failed to extend gains with the stock declining -0.05% or $-0.03 to close the day at $58.1 on lower than average trading volume of 4.16M shares, compared to its three month average trading volume of 6.36M. The Teaneck New Jersey 07666 based company has been outperforming the business software & services companies by 7.1588% for last three months and its recent gains have pushed the stock slightly up 3.69% YTD, versus the business software & services industry which is up 3.99% for the same period. The RSI of 61.2 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process services worldwide. The company operates through four segments: Financial Services, Healthcare, Manufacturing/Retail/Logistics, and Other. Its consulting and technology services include IT strategy consulting, program management consulting, operations improvement consulting, strategy consulting, and business consulting services; and application design and development, systems integration, enterprise resource planning, and customer relationship management implementation services. The company also offers enterprise information management services, such as strategic, advisory, and management consulting; enterprise data management; descriptive analytics/business intelligence; strategic corporate performance management; and packaged analytics services, as well as big data services that assist clients in managing and deriving actionable insights. In addition, it provides application testing services; and develops, licenses, implements, and supports proprietary and third-party software products, as well as offers digital technologies services. Further, the company offers outsourcing services, such as application maintenance services; IT infrastructure services; and business process services, including clinical data management, pharmacovigilance, equity research support, commercial operations, and order management. It serves various industries, including banking and insurance; healthcare and life sciences; manufacturing and logistics; retail, travel, and hospitality; consumer goods; communications; information, media, and entertainment; and technology. The company markets and sells services through its professional staff, senior management, and direct sales personnel. Cognizant Technology Solutions Corporation was founded in 1998 and is headquartered in Teaneck, New Jersey.
Medtronic plc (MDT) had a light trading with around 4.15M shares changing hands compared to its three month average trading volume of 6.67M. The stock traded between $77.16 and $78 before closing at the price of $77.99 with 0.37% change on the day. The Dublin Dublin 2 based company is currently trading 12.46% above its 52 week low of $69.35 and -12.11% below its 52 week high of $89.27. Both the RSI indicator and target price of 70.04 and $84.54 respectively, lead us to believe that it could drop over the coming weeks.
Medtronic plc manufactures and sells device-based medical therapies worldwide. The company’s Cardiac and Vascular Group segment offers pacemakers, implantable cardioverter defibrillators and cardiac resynchronization therapy devices, AF products, diagnostics and monitoring devices, and remote monitoring and patient-centered software; and heart valves, percutaneous coronary intervention stent products, surgical valve replacement and repair products, endovascular stent grafts, peripheral vascular intervention products, and products to treat superficial and deep venous diseases. Its Minimally Invasive Therapies Group segment provides gastrointestinal diagnostics, ablation, and interventional lung solutions; stapling, vessel sealing, and other surgical instruments; sutures; electrosurgery products; hernia mechanical devices; mesh implants; products for patient monitoring and recovery; sensors; monitors; compression and dialysis, enteral feeding, and wound care products; and operating room supplies, electrodes, needles, syringes, and sharps disposals. The company’s Restorative Therapies Group segment offers products for various areas of the spine; bone graft substitutes; biologic products; trauma, implantable neurostimulation therapies, and drug delivery systems for the treatment of chronic pain, movement disorders, obsessive-compulsive disorder, overactive bladder, urinary retention, fecal incontinence, and gastroparesis; products to treat conditions of the ear, nose, throat, and neurological disorders; systems that incorporate advanced energy surgical instruments; products for haemostatic sealing of soft tissue and bone; and image-guided surgery and intra-operative imaging systems. Its Diabetes Group segment provides insulin pumps and consumables; continuous glucose monitoring systems; and Web-based therapy management software solutions. It serves hospitals, physicians, clinicians, and patients. Medtronic plc was founded in 1949 and is headquartered in Dublin, Ireland.
TechnipFMC plc (FTI) traded within a range of $32.28 to $32.78 after opening the day at $32.44. The company has seen its stock decrease in value by -8.58% so far this year. The stock was down close to -0.61% on light volume in last trading session and closed at $32.48 per share. After the recent fall, the stock is currently holding -12.43% below its 52 week high of $37.09 and 40.97% above its 12-month low of $23.27. The shares are down by over -8.25% in the last three months, and the RSI indicator value of 43.25 is neither bullish nor bearish, tempting investors to stay on the sidelines.
TechnipFMC plc provides technologies, systems, and services for oil and gas projects worldwide. It operates in three segments: Subsea, Onshore/Offshore, and Surface Projects. The Subsea segment offers products, such as trees, manifolds, controls, templates, flowline systems, umbilicals, and flexibles, as well as subsea processing products. This segment also provides subsea services, including drilling, installation, completion, and field services, as well as asset management, well intervention and IMR, ROVs, and manipulator system services; and services for subsea projects comprising front end to decommissioning, field architecture, integrated design, engineering, procurement, construction, and installation services. The Onshore/Offshore segment offers technical, technological, and project management services across fixed, floating, and onshore facilities, as well as offshore services. The Surface Projects segment provides drilling, completion, and production wellhead equipment, as well as chokes, compact valves, manifolds, and controls; treating iron, manifolds, and reciprocating pumps for stimulation and cementing; separation and flow-treatment systems; flow metering products and systems; marine, truck, and railcar loading systems; installation maintenance services; frac-stack, manifold rental, and operation services; and flowback and well testing services. The company is headquartered in London, the United Kingdom.